Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first-line therapy in haemophilia patients with high responding inhibitors - Laurian,Y.D.; Tagariello,G.; Jimenez-Yuste,V. (J Thromb Haemost, 2007)